Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ChatGPT in the delivery room: proof-of-concept for live video-assisted clinical decision support in intrapartum ultrasound.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Continuous epidural infusion versus programmed-intermittent epidural bolus for labor analgesia and vacuum-assisted vaginal delivery rates: a retrospective cohort study (2020-2021).

International journal of obstetric anesthesia·2025
Same author

Impact of an interdisciplinary process to increase utilization of neuraxial anesthesia for cesarean delivery: a retrospective database analysis.

International journal of obstetric anesthesia·2024
Same author

Association between COVID-19 and subsequent vascular events in primary care patients in Germany.

Public health·2022
Same author

Mechanism and dynamics of fatty acid photodecarboxylase.

Science (New York, N.Y.)·2021
Same author

Duration of sick leave in patients with depression treated by general practitioners and psychiatrists.

Psychiatry research·2019

Related Experiment Video

Updated: May 13, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

The bottleneck in AZT activation

A Lavie1, I Schlichting, I R Vetter

  • 1Max Planck Institute for Molecular Physiology, Department of Physical Biochemistry, Dortmund, Germany.

Nature Medicine
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

The first AIDS drugs, nucleoside reverse transcriptase inhibitors like AZT, are limited by poor activation to their effective triphosphate form. Understanding thymidylate kinase

More Related Videos

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

Related Experiment Videos

Last Updated: May 13, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
14:02

Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells

Published on: April 9, 2018

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

Area of Science:

  • Biochemistry
  • Virology
  • Pharmacology

Background:

  • Nucleoside-based reverse transcriptase inhibitors (NRTIs) were the initial drugs for AIDS chemotherapy.
  • NRTIs are activated intracellularly to triphosphate forms, acting as DNA chain terminators.
  • Limited viral load reduction and drug resistance are key challenges in NRTI efficacy.

Purpose of the Study:

  • To investigate the inefficient metabolic activation of NRTIs, specifically 3'-azido-3'-deoxythymidine (AZT).
  • To elucidate the reasons behind the poor substrate properties of AZT monophosphate (AZTMP) for thymidylate kinase.

Main Methods:

  • Structural determination of thymidylate kinase in complex with AZTMP.
  • Kinetic studies of AZTMP phosphorylation by thymidylate kinase.

Main Results:

  • AZT requires intracellular activation to its triphosphate form for antiviral activity.
  • Phosphorylation of AZT to AZTMP is efficient, but AZTMP is a poor substrate for thymidylate kinase.
  • This inefficient step significantly limits the intracellular concentration of active AZT triphosphate.

Conclusions:

  • Inefficient metabolic activation, particularly the poor substrate properties of AZTMP for thymidylate kinase, limits NRTI efficacy.
  • Structural and kinetic insights explain the low achievable concentrations of active AZT triphosphate.
  • Understanding these mechanisms is crucial for developing more effective anti-HIV therapies.